×
We recently upgraded the website!  If you run into any issues, please Contact Us.  We'd also love to hear your feedback!  Enjoy exploring the new site!

San Francisco Bay Area Chapter In Person Event: 2026 Risks with Pharmaceutical & Medical Devices in the Supply Chain

This intensive symposium covers the 2026 pharmaceutical and medical device landscape, focusing on global supply chain integrity, GDP, and the latest GMP updates.

Navigating the Future of Pharma: Global Regulatory & Supply Chain Forum

As global supply chains grow increasingly complex and regulatory scrutiny intensifies, staying ahead of compliance is no longer optional—it’s a strategic necessity.

On April 7th, 2026, join an elite group of regulatory experts and quality assurance professionals for a full day of high-impact learning. This forum is designed to bridge the gap between emerging global regulations and practical operational excellence, providing the tools needed to maintain resilience in a volatile market.

Why Attend?

This event provides a 360-degree view of the pharmaceutical and device lifecycle—from raw materials to complex Biologics and Combination Products. You will gain direct insights into the trends shaping the industry:

  • Global Perspectives: Gain the latest updates on global regulatory shifts and supply chain trends impacting the 2026–2028 term.
  • Technical Deep Dives: Explore Good Distribution Practices (GDP) for APIs and finished products, alongside the complex analytical journey of Biologics.
  • Guidance on Combo-Devices: Navigate the intricate rules and regulations governing medical device combinations and their integration into the pharma space.
  • Risk Mitigation: Identify common audit non-conformances, GMP requirements, and legal risks before they impact your business.

Learning Objectives

  • Analyze the impact of current global regulatory updates on manufacturing and distribution standards.
  • Evaluate compliance strategies for GDP across the entire supply chain, from raw materials to finished pharma products.
  • Navigate the evolving regulatory framework for Combination Medical Devices in domestic and international markets.
  • Identify common audit pitfalls and legal risks to improve organizational "audit readiness."
  • Assess technical requirements specific to the development and scaling of Biologic drugs.

Agenda

8:30-9:30 am Registration & Breakfast

09:30-10:30 Session 1

  • Welcome & RAPS Global Regulatory Update, Heinz Steneberg, MDSS
  • Global Regulatory Supply Chain Update, Hank Karayan, Head of Pharma & Cosmetics, SGS
  • APIs, Finished Pharma Product, Storage & Distribution (GDP), Jon Gawlak, Technical Manager/Senior Auditor, SGS

10:30-10:45 Break

10:45-12:15 Session 2

  • EXCiPACT GMP & PAMs Update, Iain Moore, Senior Advisor Operations, IPEC
  • Combo Device Rules & Regulations Update, Mingxiang Xu, Technical Director, Medical Devices, SGS
  • Panel Discussion (Speakers from Session 1 & 2)

12:15-1:00 Lunch

1:00-2:30 Session 3

  • Customer Perspective on Combo-Medical Devices, James Wabby, Head of Global Regulatory Affairs, AbbVie & Adjunct Assistant Professor, USC, School of Pharmacy – Regulatory and Quality Sciences
  • Audit Risks & Common Non-Conformances in the Pharmaceutical Supply Chain, Jon Gawlak, Technical Manager/Senior Auditor, SGS
  • Analytical Journey of Biologics Drugs, Greg Adams, Head of Biopharma Science, SGS

2:30-2:45 Break

2:45-4:00 Session 4

  • Legal Update in the Pharmaceutical Industry,
  • Supply Chain Risks & Solutions, Jon Gawlak, Technical Manager/Senior Auditor, SGS
  • Panel Discussion (Speakers from Session 3 & 4)

4:00-6:00 pm Reception/Happy Hour

 

Location

Crowne Plaza Foster City-San Mateo
1221 Chess Dr
Foster City, California 94404

Cancellations and Refunds

RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.

Substitutions

Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.

Proof of Attendance

A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.

Questions

Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].  

Speakers

Heinz  Steneberg

Heinz Steneberg

President & CEO, MDSS USA

Find out more

Greg Adams

Greg Adams

Head of Biopharma Science, SGS North America

Find out more

Jon  Gawlak

Jon Gawlak

Technical Manager/Senior Auditor, SGS North America

Find out more

Mingxiang  Xu

Mingxiang Xu

Technical Director, SGS North America

Find out more

Jessica Nicole  Cansler

Jessica Nicole Cansler

Board Member, EXCiPACT

Find out more

Hank  Karayan

Hank Karayan

Global Head of Cosmetics and Pharma Assurance, Global FSMA Program Director

Find out more

 

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.